Similar articles for PMID: 22241912

Year	Number of Results
1982	1
1991	1
1995	2
1996	2
1997	2
1998	1
1999	2
2000	1
2001	2
2002	2
2003	1
2004	9
2006	3
2007	9
2008	10
2009	4
2010	4
2011	10
2012	10
2013	12
2014	6
2015	8
2016	14
2017	12
2018	9
2019	7
2020	19
2021	18
2022	16
2023	8
2024	0

1

PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma.

van Kruchten M, Glaudemans AW, de Vries EF, Beets-Tan RG, Schröder CP, Dierckx RA, de Vries EG, Hospers GA. van Kruchten M, et al. J Nucl Med. 2012 Feb;53(2):182-90. doi: 10.2967/jnumed.111.092734. Epub 2012 Jan 12. J Nucl Med. 2012. PMID: 22241912 Free article.

2

Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?

Yang Z, Sun Y, Zhang Y, Xue J, Wang M, Shi W, Zhu B, Hu S, Yao Z, Pan H, Zhang Y. Yang Z, et al. Clin Breast Cancer. 2013 Oct;13(5):359-63. doi: 10.1016/j.clbc.2013.02.012. Epub 2013 Jun 17. Clin Breast Cancer. 2013. PMID: 23787040

3

Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.

van Kruchten M, de Vries EF, Arts HJ, Jager NM, Bongaerts AH, Glaudemans AW, Hollema H, de Vries EG, Hospers GA, Reyners AK. van Kruchten M, et al. J Nucl Med. 2015 Jan;56(1):50-5. doi: 10.2967/jnumed.114.147579. Epub 2014 Dec 4. J Nucl Med. 2015. PMID: 25476534 Free article.

4

The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.

Sun Y, Yang Z, Zhang Y, Xue J, Wang M, Shi W, Zhu B, Hu S, Yao Z, Pan H, Zhang Y. Sun Y, et al. PLoS One. 2015 Jan 24;10(1):e0116341. doi: 10.1371/journal.pone.0116341. eCollection 2015. PLoS One. 2015. PMID: 25617853 Free PMC article.

5

Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.

Gemignani ML, Patil S, Seshan VE, Sampson M, Humm JL, Lewis JS, Brogi E, Larson SM, Morrow M, Pandit-Taskar N. Gemignani ML, et al. J Nucl Med. 2013 Oct;54(10):1697-702. doi: 10.2967/jnumed.112.113373. Epub 2013 Aug 22. J Nucl Med. 2013. PMID: 23970364 Free PMC article. Clinical Trial.

6

Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.

Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ. Mortimer JE, et al. Clin Cancer Res. 1996 Jun;2(6):933-9. Clin Cancer Res. 1996. PMID: 9816253

7

Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.

Talbot JN, Gligorov J, Nataf V, Montravers F, Huchet V, Michaud L, Ohnona J, Balogova S, Cussenot O, Daraï E, Lotz JP, Kerrou K. Talbot JN, et al. Q J Nucl Med Mol Imaging. 2015 Mar;59(1):4-17. Epub 2015 Feb 19. Q J Nucl Med Mol Imaging. 2015. PMID: 25693420 Free article. Review.

8

Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.

Kurland BF, Wiggins JR, Coche A, Fontan C, Bouvet Y, Webner P, Divgi C, Linden HM. Kurland BF, et al. Oncologist. 2020 Oct;25(10):835-844. doi: 10.1634/theoncologist.2019-0967. Epub 2020 May 15. Oncologist. 2020. PMID: 32374053 Free PMC article. Review.

9

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.

Venema CM, Mammatas LH, Schröder CP, van Kruchten M, Apollonio G, Glaudemans AWJM, Bongaerts AHH, Hoekstra OS, Verheul HMW, Boven E, van der Vegt B, de Vries EFJ, de Vries EGE, Boellaard R, Menke van der Houven van Oordt CW, Hospers GAP. Venema CM, et al. J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14. J Nucl Med. 2017. PMID: 28912144 Free article. Clinical Trial.

10

¹⁸F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.

Nienhuis HH, van Kruchten M, Elias SG, Glaudemans AWJM, de Vries EFJ, Bongaerts AHH, Schröder CP, de Vries EGE, Hospers GAP. Nienhuis HH, et al. J Nucl Med. 2018 Aug;59(8):1212-1218. doi: 10.2967/jnumed.117.198846. Epub 2018 Mar 30. J Nucl Med. 2018. PMID: 29602822 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

176 results

Results by year